|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Operating expenses: | |||
| Research and development | |||
| General and administrative | |||
| Total operating expenses | |||
| Loss from operations | |||
| Other income (expense): | |||
| Interest income | |||
| Interest expense | |||
| Loss on debt extinguishment | |||
| Other income, net | |||
| Net loss | |||
| Preferred stock deemed dividend | |||
| Net loss attributable to common stockholders | |||
| Loss per share, basic (in dollars per share) | |||
| Loss per share, diluted (in dollars per share) | |||
| Weighted average number of shares of common stock, basic (in shares) | |||
| Weighted average number of shares of common stock, diluted (in shares) |
Loading...
